Consumo de Antibióticos y su Relación con el Desarrollo de Anemia Hemolítica Autoinmune
Resumen
La anemia hemolítica autoinmune se caracteriza por ser un trastorno de carácter inmunitario en el cual se da la presencia de anticuerpos dirigidos contra antígenos presentes en la membrana eritrocitaria dando como consecuencia la disminución de la vida media o destrucción de los hematíes. Según su epidemiología, puede presentarse a cualquier edad y sus causas pueden ser variadas, e incluso su asociación con el consumo de diferentes fármacos como los antibióticos, especialmente penicilinas y cefalosporinas, aunque es poco frecuente es de gran importancia debido a la afectación de la calidad de vida del paciente. Por ende, realizamos una búsqueda bibliográfica de artículos en inglés y español en diferentes bases de datos dando como resultado diferentes reportes de casos que nos dan a conocer la relación en el desarrollo de anemia hemolítica autoinmune como consecuencia del consumo de antibióticos.
Descargas
Citas
S. Vaglio, M.C. Arista, M.P. Perrone, G. Tomei, A.M. Testi, S. Coluzzi, et al. Autoimmune hemolytic anemia in childhood: serologic features in 100 cases Transfusion., 47 (2007), pp. 50-54
N. Aladjidi, M.A. Jutand, C. Beaubois, H. Fernandes, J. Jeanpetit, G. Coureau, et al. Reliable assessment of the incidence of childhood autoimmune hemolytic anemia Pediatr Blood Cancer., 64 (2017), pp. 1-19
S.T. Chou, A.D. Schreiber Autoimmune hemolytic anemia. In: Nathan and Oski's Hematology and Oncology of Infancy and Childhood (8th ed.), Saunders, Philadelphia (2015), p. 411
Bass GF, Tuscano MT, Tuscano JM. Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev 2014; 13: 560-4
Barcellini, W., & Fattizzo, B. (2020). The Changing Landscape of Autoimmune Hemolytic Anemia. Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.00946
Baralt Zamudio R, Campos S. Autoimmune hemolytic anemia. From lab to bedside Asian J Transfus Sci. 2014; 8 Edicion: p.
Ronald S. Go , Jeffrey L. Winters , Neil E. Kay. How I treat autoimmune hemolytic anemia. Blood. 2017; 129(22): p.
Barcellini , Zaninoni , Alessandro Giannotta , Fattizzo. New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy. Journal of clinical Medicine. 2020; 9(12):p.
Pullarkat V, Ngo M, Iqbal S, et al. Detection of lupus anticoagulant identifies patients with autoimmune hemolytic anemia at increased risk for venous thrombosis. Br J Haematol 2002;118:1166–9.
Roumier M, Loustau V, Guillaud C, et al. Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single-center experience with 60 patients. Am J Hematol 2014;89:E150–5.
D.Renard , A.Rosselet. Drug-induced hemolytic anemia: Pharmacological aspects. Transfusion Clinique et Biologique. 2017; 24(3): p. 10.1016/j.tracli.2017.05.013
Bencomo Hernández A, Alfonso Valdés M, Correa Palmero , Macias Abraham , Avila Cabrera M, Hernández Padrón. Relación entre la concentración de autoanticuerpos IgG en los hematíes con la respuesta al tratamiento en pacientes con anemia hemolítica autoinmune. Rev Cubana Hematol Inmunol Hemoter. 2013; 29(2): p.
http://www.revhematologia.sld.cu/index.php/hih/article/view/42/50
De Wilde, Maarten, et al. "Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of ‘chronic Lyme disease’." Acta clinica Belgica 72.2 (2017): 133-137.
Tang, Linlin, et al. "A Real-World Disproportionality Analysis of Drug-Induced Immune Hemolytic Anemia in the FDA Adverse Event Reporting System." Annals of Pharmacotherapy (2023): 10600280231189897.
Maquet, Julien, et al. "Drug-Induced Immune Hemolytic Anemia: Detection of New Signals and Risk Assessment in a Nationwide Cohort Study." Blood Advances (2023): bloodadvances-2023009801.
Petz LD, Garratty G. Immune Hemolytic Anemias. 2nd ed. Philadelphia: Churchill Livingstone; 2004:261– 317.
Garratty G, Arndt P, Prince HE, Shulman IA. The effect of methyldopa and procainamide on suppressor cell activity in relation to red cell autoantibody production. Br J Haematol. 1993;84:310–315
Viraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adv Drug React Toxicol Rev. 2002;21:101–107.
Kapur G, Valentini RP, Mattoo TK, Warrier I, Imam AA. Ceftriaxone induced hemolysis complicated by acute renal failure. Pediatr Blood Cancer. 2008;50:139–142.
Martínez, Alejandro Hernández, et al. "Hemolytic anemia associated with antimicrobial drugs." Enfermedades Infecciosas y Microbiología 38.3 (2019): 81-85.
Salama, Abdulgabar. "Drug-induced immune hemolytic anemia." Expert opinion on drug safety 8.1 (2009): 73-79.
Garbe E, Andersohn F, Bronder E, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Grüneisen A, Mayer B, Salama A, Kurtal H. Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. Br J Haematol. 2011 Sep;154(5):644-53. doi: 10.1111/j.1365-2141.2011.08784.x. Epub 2011 Jul 12. PMID: 21749359.
Chan Gomez J, Saleem T, Snyder S, Joseph M, Kanderi T. Drug-Induced Immune Hemolytic Anemia due to Amoxicillin-Clavulanate: A Case Report and Review. Cureus. 2020 Jun 17;12(6):e8666. doi: 10.7759/cureus.8666. PMID: 32699666; PMCID: PMC7370667.
Kiblawi, Mahmoud. "Early-onset antibiotic-induced autoimmune hemolytic anemia." Ibnosina Journal of Medicine and Biomedical Sciences 12.03 (2020): 215-219.
ABU-HASHISH, H. U. S. S. E. I. N., et al. "CEFTRIAXONE-INDUCED HEMOLYTIC ANEMIA WITH SUBSEQUENT RENAL FAILURE." CHEST 164.4 (2023): A2519.
Taherahmadi, Hassan, Javad Nazari, and Manijeh Kahbazi. "Antibiotic induced hemolytic anemia and thrombocytopenia among pediatric patients admitted to intensive care unit." Iranian Journal of Pediatric Hematology & Oncology (2019).
Boilève, Alice, et al. "Acute and fatal cephalosporin‐induced autoimmune haemolytic anaemia." British Journal of Clinical Pharmacology 87.4 (2021): 2152-2156.
Catral, J. Hitchcock, E. Ceftriaxone-Induced Immune Hemolytic Anemia from Treatment of Post-Treatment Lyme Disease Syndrome. Providence St. Vincent Internal Medicine. 2020. 6
Karunathilaka, H. Chandrasiri, D. Ranasinghe, P. Ratnamalala, V. Fernando, A. Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report. Case Reports in Hematology, 2020. vol. 2020, Article ID 9841097, 3 pages.
Rehman, A. Keohane, C. Crowley, M. Whelan, L. Gallwey, N. Brady, C. O’Reilly, S. A case of life threatening acute Nivolumab induced autoimmune haemolytic anaemia. Curr Cancer Rep, 2022, 4(1): 133-138
Mause, E. Selim, M. Velagapudi, M. Cefazolin-induced hemolytic anemia: a case report and systematic review of literature. European Journal of Medical Research (2021) 26:133
Kumar, S. Bansal, R. Bansal, P. Kumar, R. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report. Perm J 2020;24:19.088
Derechos de autor 2023 Jose Camilo Meza Figueroa, Jesús David Doria Galvis, Juan Sebastian Avila Medrano, María Carolina Alvarez Castro, Ana Elisa Martínez Guzmán, Stefany del Carmen Díaz Burgos
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.jpg)
